Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,836,846
-$271,962 QoQ
Shares Held
76,281
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,001
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. PFE ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
This page
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,836,846 | 76,281 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,108,808 | 75,100 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,891,204 | 75,952 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,158,614 | 84,718 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,279,214 | 94,027 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,194,993 | 126,085 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,630,980 | 99,170 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,864,394 | 98,977 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,767,305 | 98,903 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,791,095 | 100,580 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,505,067 | 121,746 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,203,226 | 96,570 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,622,700 | 98,765 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,372,128 | 107,160 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,564,202 | 108,591 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,783,580 | 109,314 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,874,519 | 112,045 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,024,578 | 116,372 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,921,663 | 117,217 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,937,289 | 114,794 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,538,761 | 115,903 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,198,223 | 115,877 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,238,119 | 115,135 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,801,272 | 103,577 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,380,366 | 72,794 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,106,550 | 64,539 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||